$54.84
$0.29
(0.52%)
Quote as of 12:57 PM EST on 02/15/12
Gilead Sciences
NASDAQ:GILD
|
$54.84
$0.29
(0.52%)
|
|
| Today's Open | $54.90 |
|---|---|
| Previous Close | $54.56 |
| Daily Range | $54.07 - $54.90 |
| 52-Week Range | $34.45 - $56.50 |
| Market Cap | $41.19B |
| P/E Ratio | 15.91 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,449,615 |
| Average Daily Volume | 10,395,946 |
| Current FY EPS | $3.73 |
GILD Information
| Description |
|---|
| Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Weak Revenues Pull Down Actelion - Analyst Blog
US STOCK FUTURES: HOT STOCKS TO WATCH
US STOCK FUTURES: HOT STOCKS TO WATCH
Has Johnson & Johnson Become the Perfect Stock?
Will Pfizer Help You Retire Rich?
Gilead: FDA Fast Tracks Review Of HIV Drug Truvada
Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF,
24/7 Wall St. Closing Bell (COP, GILD, AMSC, MA, COH, LNKD, ATVI, CPST, GPRE, KONA, TRLG, LGF, MOVE,
